Hopebridge

Hopebridge, founded in 2005, is a prominent healthcare provider specializing in pediatric therapy for children with autism spectrum disorder. The organization focuses on early intensive behavioral intervention (EIBI) through applied behavior analysis (ABA) to support developmental milestones. By offering comprehensive services including speech therapy, occupational therapy, and diagnostic assessments, Hopebridge addresses the critical needs of children aged 15 months to 10 years. Their interdisciplinary approach ensures that each child receives a personalized therapy plan designed to foster growth in a supportive, clinical environment.

Operating with a workforce of 5,000-10,000 employees, Hopebridge maintains a robust operational footprint across 57 locations. The company prioritizes reducing wait times for evaluations, facilitating access to care for families in underserved communities. Meet Hopebridge's team to learn about the clinical leadership and specialized staff driving these therapeutic outcomes. Their commitment to high-quality, compassionate care is reflected in their state-of-the-art facilities and the integration of one-on-one behavioral health services.

With annual revenue reaching $734.0M, Hopebridge demonstrates significant market presence within the competitive landscape of autism therapy providers. The company has successfully secured multiple rounds of private equity and debt funding to scale its operations and enhance its service delivery model. Explore financial highlights for detailed metrics regarding their fiscal performance and growth trajectory. As a key player in the healthcare sector, Hopebridge continues to collaborate with insurance providers to expand the reach of their behavioral intervention programs across North America.